author-photo

Gaetan de Schaetzen

European Organisation for Research and Treatment of Cancer

14

Papers

1938

Citations

Citation Trend

Filter By

Papers (14) Sort By

Journal Conference Others

Fertility status among long-term childhood acute lymphoblastic leukaemia survivors enrolled between 1971 and 1998 in EORTC CLG studies: results of the 58 Late Adverse Effects study.

2021 Human Reproduction
Show All
- Source
- Cite
- Save
Citations (0)
Survival Improvement over Time of 960 s-AML Patients Included in 13 EORTC-GIMEMA-HOVON Trials.

2020 Cancers
Show All
- Source
- Cite
- Save
Citations (6)
Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors

2020 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (5)
Lessons learnt from the medical and psychosocial evaluation of childhood acute lymphoblastic leukemia (ALL) survivors enrolled in EORTC Children Leukemia Group Trials between 1971 and 1998 and future perspectives for long-term outcome research

2018 Journal of cancer policy
Show All
- Source
- Cite
- Save
Citations (2)
Relapse-Free Survival as a Surrogate for Overall Survival in the Evaluation of Stage II-III Melanoma Adjuvant Therapy.

2018 Journal of the National Cancer Institute
Show All
- Source
- Cite
- Save
Citations (40)
Randomized phase III trial of intravenous (IV) versus hepatic intra-arterial (HIA) fotemustine in patients with liver metastases from uveal melanoma: Final results of the EORTC 18021 study.

2017 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (9)
Long term follow up of the EORTC 18952 trial of adjuvant therapy in resected stage IIB-III cutaneous melanoma patients comparing intermediate doses of interferon-alpha-2b (IFN) with observation: Ulceration of primary is key determinant for IFN-sensitivity

2016 European Journal of Cancer
Show All
- Source
- Cite
- Save
Citations (61)
Prolonged survival in stage III melanoma with ipilimumab adjuvant therapy

2016 The New England Journal of Medicine
Show All
- Source
- Cite
- Save
Citations (813)
Adjuvant ipilimumab versus placebo after complete resection of high-risk stage III melanoma (EORTC 18071): a randomised, double-blind, phase 3 trial

2015 Lancet Oncology
Show All
- Source
- Cite
- Save
Citations (788)
The international rare cancers initiative.

2014 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)